Acasti Pharma Inc. (ACST)
NASDAQ: ACST · Real-Time Price · USD
3.270
-0.080 (-2.39%)
Oct 14, 2024, 4:00 PM EDT - Market closed

Acasti Pharma Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Acasti Pharma stock have an average target of 10, with a low estimate of 8.00 and a high estimate of 12. The average target predicts an increase of 205.81% from the current stock price of 3.27.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $8.00 $10 $12 $12
Change +144.65% +205.81% +266.97% +266.97%

Analyst Ratings

The average analyst rating for Acasti Pharma stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 222222
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong Buy Reiterates $12 +266.97% Sep 26, 2024
Craig-Hallum
Craig-Hallum
Strong Buy
Maintains
$6$8
Strong Buy Maintains $6$8 +144.65% Sep 26, 2024
Craig-Hallum
Craig-Hallum
Strong Buy
Initiates
$6
Strong Buy Initiates $6 +83.49% Feb 7, 2024
EF Hutton
EF Hutton
Strong Buy
Reiterates
$15
Strong Buy Reiterates $15 +358.72% Feb 15, 2023
EF Hutton
EF Hutton
Strong Buy
Initiates
$15
Strong Buy Initiates $15 +358.72% Dec 19, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
1.24M
EPS This Year
-2.19
from -1.35
EPS Next Year
-1.78
from -2.19
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Mar 31, 2020 Mar 31, 2021 Mar 31, 2022 Mar 31, 2023 Mar 31, 2024 Mar 31, 2025 Mar 31, 2026
Revenue
-196.00K----1.24M
Revenue Growth
-------
EPS
-14.48-7.96-1.60-5.71-1.35-2.19-1.78
EPS Growth
-------
Forward PE
-------
No. Analysts -----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High n/a 1.3M
Avg n/a 1.2M
Low n/a 1.2M

Revenue Growth

Revenue Growth 20242025
High - -
Avg - -
Low - -

EPS Forecast

EPS 20242025
High -2.26 -1.83
Avg -2.19 -1.78
Low -2.11 -1.71

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.